146 related articles for article (PubMed ID: 22358885)
1. Concanamycin A, a vacuolar type H(+)-ATPase inhibitor, induces cell death in activated CD8(+) CTL.
Togashi K; Kataoka T; Nagai K
Cytotechnology; 1997 Nov; 25(1-3):127-35. PubMed ID: 22358885
[TBL] [Abstract][Full Text] [Related]
2. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
Kataoka T; Shinohara N; Takayama H; Takaku K; Kondo S; Yonehara S; Nagai K
J Immunol; 1996 May; 156(10):3678-86. PubMed ID: 8621902
[TBL] [Abstract][Full Text] [Related]
3. Acidification is essential for maintaining the structure and function of lytic granules of CTL. Effect of concanamycin A, an inhibitor of vacuolar type H(+)-ATPase, on CTL-mediated cytotoxicity.
Kataoka T; Takaku K; Magae J; Shinohara N; Takayama H; Kondo S; Nagai K
J Immunol; 1994 Nov; 153(9):3938-47. PubMed ID: 7930604
[TBL] [Abstract][Full Text] [Related]
4. Prodigiosin 25-C suppression of cytotoxic T cells in vitro and in vivo similar to that of concanamycin B, a specific inhibitor of vacuolar type H(+)-ATPase.
Lee MH; Kataoka T; Magae J; Nagai K
Biosci Biotechnol Biochem; 1995 Aug; 59(8):1417-21. PubMed ID: 7549091
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a series of vacuolar type H(+)-ATPase inhibitors on CTL-mediated cytotoxicity.
Togashi K; Kataoka T; Nagai K
Immunol Lett; 1997 Mar; 55(3):139-44. PubMed ID: 9161879
[TBL] [Abstract][Full Text] [Related]
6. ECH, an epoxycyclohexenone derivative that specifically inhibits Fas ligand-dependent apoptosis in CTL-mediated cytotoxicity.
Mitsui T; Miyake Y; Kakeya H; Osada H; Kataoka T
J Immunol; 2004 Mar; 172(6):3428-36. PubMed ID: 15004142
[TBL] [Abstract][Full Text] [Related]
7. Inactivation and proteolytic degradation of perforin within lytic granules upon neutralization of acidic pH.
Kataoka T; Togashi K; Takayama H; Takaku K; Nagai K
Immunology; 1997 Jul; 91(3):493-500. PubMed ID: 9301542
[TBL] [Abstract][Full Text] [Related]
8. In vivo rapid reduction of alloantigen-activated CD8+ mature cytotoxic T cells by inhibitors of acidification of intracellular organelles, prodigiosin 25-C and concanamycin B.
Lee MH; Kataoka T; Honjo N; Magae J; Nagai K
Immunology; 2000 Feb; 99(2):243-8. PubMed ID: 10692043
[TBL] [Abstract][Full Text] [Related]
9. Estimation of pH and the number of lytic granules in a CD8+ CTL clone treated with an inhibitor of vacuolar type H(+)-ATPase concanamycin A.
Kataoka T; Sato M; Kondo S; Nagai K
Biosci Biotechnol Biochem; 1996 Oct; 60(10):1729-31. PubMed ID: 8987677
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide production by the vacuolar-type (H+)-ATPase inhibitors bafilomycin A1 and concanamycin A and its possible role in apoptosis in RAW 264.7 cells.
Hong J; Nakano Y; Yokomakura A; Ishihara K; Kim S; Kang YS; Ohuchi K
J Pharmacol Exp Ther; 2006 Nov; 319(2):672-81. PubMed ID: 16895977
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27.
Morishima N; Owaki T; Asakawa M; Kamiya S; Mizuguchi J; Yoshimoto T
J Immunol; 2005 Aug; 175(3):1686-93. PubMed ID: 16034109
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of lysis by cytotoxic T lymphocyte clones. Lytic activity and gene expression in cloned antigen-specific CD4+ and CD8+ T lymphocytes.
Lancki DW; Hsieh CS; Fitch FW
J Immunol; 1991 May; 146(9):3242-9. PubMed ID: 1673149
[TBL] [Abstract][Full Text] [Related]
13. Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans.
Yasukawa M; Ohminami H; Arai J; Kasahara Y; Ishida Y; Fujita S
Blood; 2000 Apr; 95(7):2352-5. PubMed ID: 10733506
[TBL] [Abstract][Full Text] [Related]
14. Identification of low molecular weight probes on perforin- and Fas-based killing mediated by cytotoxic T lymphocytes.
Kataoka T; Taniguchi M; Yamada A; Suzuki H; Hamada S; Magae J; Nagai K
Biosci Biotechnol Biochem; 1996 Oct; 60(10):1726-8. PubMed ID: 8987676
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylinositol 3-kinase inhibitors prevent mouse cytotoxic T-cell development in vitro.
Phu T; Haeryfar SM; Musgrave BL; Hoskin DW
J Leukoc Biol; 2001 May; 69(5):803-14. PubMed ID: 11358990
[TBL] [Abstract][Full Text] [Related]
16. CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection.
Mieno M; Suto R; Obata Y; Udono H; Takahashi T; Shiku H; Nakayama E
J Exp Med; 1991 Jul; 174(1):193-201. PubMed ID: 1905338
[TBL] [Abstract][Full Text] [Related]
17. Induction of lytic pathways in T cell clones derived from wild-type or protein tyrosine kinase Fyn mutant mice.
Lancki DW; Fields P; Qian D; Fitch FW
Immunol Rev; 1995 Aug; 146():117-44. PubMed ID: 7493751
[TBL] [Abstract][Full Text] [Related]
18. Distinct pathways of CD4 and CD8 cells induce rapid target DNA fragmentation.
Ju ST
J Immunol; 1991 Feb; 146(3):812-8. PubMed ID: 1671051
[TBL] [Abstract][Full Text] [Related]
19. Two types of anti-TL (thymus leukemia) CTL clones with distinct target specificities: differences in cytotoxic mechanisms and accessory molecule requirements.
Tsujimura K; Takahashi T; Iwase S; Matsudaira Y; Kaneko Y; Yagita H; Obata Y
J Immunol; 1998 Jun; 160(11):5253-61. PubMed ID: 9605121
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of CPP32-like proteases prevents granzyme B- and Fas-, but not granzyme A-based cytotoxicity exerted by CTL clones.
Anel A; Gamen S; Alava MA; Schmitt-Verhulst AM; Piñeiro A; Naval J
J Immunol; 1997 Mar; 158(5):1999-2006. PubMed ID: 9036942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
